Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by GrahamBon Mar 28, 2021 11:48am
303 Views
Post# 32894840

RE:RE:VPT and COVID

RE:RE:VPT and COVID
MoPeter wrote:

Ventripoint has units installed in some of the largest, most reputable cardiac centres in the world, including but not limited to:
-MD Anderson (US)
-Erasmus university (Netherlands) 
-Peter Munk(Toronto)
-The Maz/Stollery (Edmonton)
-Kings College (London)
 Not to mention the interest and apparent demand in China for a 2 generations old version

I'm not going to argue the paper you just wrote, some of the concerns you raised could be valid. Maybe. However, I myself refuse to believe that all of these major institutions with some of the best doctors in their field would waste precious time and assets on a device if it either didn't work or wasn't of practical use. They wouldn't even let them through the door. Studies indeed have been and are currently being done. If I'm not mistaken, a comparability study between VMS and MRI was even published in a journal.

 We also know that there will be an alliance with a large healthcare company likely in the next month. That will happen. At this point it's not a rumour.  Again, if the tech wasn't the least bit useful or if there wasn't the potential to make serous money, would a large company waste their efforts on it? I really doubt it

 

[/quote



Mo-

Thanks for your thoughts.
 

I agree, with the spirit of what you are saying-it seems logical.
 

The question I have is in confirming these thoughts.
 

To the point:
 

1.Ventripoint has as you say units installed in some of the largest, most reputable cardiac centres in the world
-granted 

But what were the terms of the installations?.
Were they give aways/free units  to promote KOLs to use and support the technology.(I believe so)

This is a lost leader strategy, and  if so, and has yet to prove viable. What research institution wouldn’t turn down a free machine?
How does this translate into actual sales-VPT has been around a decade-its time to see actual sales

 

 

 2. Regarding China-havent seen any sales data, and risks of technology transfer remain.
 

 

  1. The studies I have seen are older, and don’t address the growing AI developments, and importantly advances in echo (which is the real comparator)

 

4. The EXPECTED alliance with a lhealthcare company  remains unconfirmed , and I haven’t seen any of the financial details
Alliance is a loose term. What exactly does this mean?
Can anyone provide finacial data/terms?

<< Previous
Bullboard Posts
Next >>